0001104659-20-049559 Sample Contracts

AMENDMENT AND EXCHANGE AGREEMENT
And • April 22nd, 2020 • Ocugen, Inc. • Biological products, (no disgnostic substances) • New York

This AMENDMENT AND EXCHANGE AGREEMENT (the “Agreement”) is made as of April 22, 2020, by and among Ocugen, Inc., a Delaware corporation formerly known as Histogenics Corporation (the “Company”), Ocugen OpCo, Inc., a Delaware corporation formerly known as Ocugen, Inc. (“OpCo”), and the investor signatory hereto (the “Investor”).

AutoNDA by SimpleDocs
Time is Money Join Law Insider Premium to draft better contracts faster.